Revvity Inc (RVTY)
124.00
-0.86
(-0.69%)
USD |
NYSE |
Nov 07, 16:00
124.02
+0.02
(+0.02%)
After-Hours: 20:00
Revvity Revenue (TTM): 2.722B for Sept. 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 2.722B |
| June 30, 2024 | 2.708B |
| March 31, 2024 | 2.726B |
| December 31, 2023 | 2.751B |
| September 30, 2023 | 2.796B |
| June 30, 2023 | 2.837B |
| March 31, 2023 | 3.024B |
| December 31, 2022 | 3.312B |
| September 30, 2022 | 3.599B |
| June 30, 2022 | 3.748B |
| March 31, 2022 | 4.081B |
| December 31, 2021 | 4.425B |
| September 30, 2021 | 3.633B |
| June 30, 2021 | 3.735B |
| March 31, 2021 | 3.319B |
| December 31, 2020 | 2.663B |
| September 30, 2020 | 3.234B |
| June 30, 2020 | 2.977B |
| March 31, 2020 | 2.887B |
| December 31, 2019 | 2.884B |
| September 30, 2019 | 2.835B |
| June 30, 2019 | 2.802B |
| March 31, 2019 | 2.783B |
| December 31, 2018 | 2.778B |
| September 30, 2018 | 2.663B |
| Date | Value |
|---|---|
| June 30, 2018 | 2.543B |
| March 31, 2018 | 2.387B |
| December 31, 2017 | 2.257B |
| September 30, 2017 | 2.182B |
| June 30, 2017 | 2.142B |
| March 31, 2017 | 2.132B |
| December 31, 2016 | 2.116B |
| September 30, 2016 | 1.999B |
| June 30, 2016 | 2.048B |
| March 31, 2016 | 2.076B |
| December 31, 2015 | 2.105B |
| September 30, 2015 | 2.095B |
| June 30, 2015 | 2.074B |
| March 31, 2015 | 2.066B |
| December 31, 2014 | 2.070B |
| September 30, 2014 | 2.221B |
| June 30, 2014 | 2.201B |
| March 31, 2014 | 2.185B |
| December 31, 2013 | 2.160B |
| September 30, 2013 | 2.131B |
| June 30, 2013 | 2.119B |
| March 31, 2013 | 2.100B |
| December 31, 2012 | 2.105B |
| September 30, 2012 | 2.082B |
| June 30, 2012 | 2.025B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
2.663B
Minimum
Dec 2020
4.425B
Maximum
Dec 2021
3.203B
Average
3.000B
Median
Revenue (TTM) Benchmarks
| Bionano Genomics Inc | 36.58M |
| Avantor Inc | 6.820B |
| Bruker Corp | 3.241B |
| Azenta Inc | 658.62M |
| Harvard Bioscience Inc | 101.12M |